Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
HTG Molecular Diagnostics, Inc. (HTGMQ) Income from Continuous Operations data is not available for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$6.37M |
|
$-21.59M |
|
$4.57M |
|
$1.79M |
|
$27.20M |
|
$-20.83M |
|
$-0.75M |
|
$-21.58M |
|
$-21.58M |
|
-- |
|
|
Income from Continuous Operations |
-- |
$-21.59M |
|
-- |
|
$-20.83M |
|
$-19.84M |
|
0.89M |
|
0.89M |
|
$-24.28 |
|
$-24.28 |
|
| Balance Sheet Financials | |
$15.65M |
|
$0.60M |
|
$2.13M |
|
$17.78M |
|
$8.27M |
|
-- |
|
$4.12M |
|
$12.39M |
|
$5.39M |
|
$5.39M |
|
$5.39M |
|
2.21M |
|
| Cash Flow Statement Financials | |
$-18.41M |
|
$12.42M |
|
$8.60M |
|
$9.60M |
|
$12.21M |
|
$2.61M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
-- |
|
0.71 |
|
28.18% |
|
-327.19% |
|
-327.19% |
|
-311.66% |
|
-339.03% |
|
-339.20% |
|
$-18.33M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
5.03 |
|
4.48 |
|
81.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
$2.44 |
|
$-20.62 |
|
$-20.71 |
|